Cleveland BioLabs, Inc. reported current assets of US$8,423,141
and current liabilities of US$17,610,644 at March 31, 2010, for a
working capital deficit of US$9,187,503.
provides timely updates on public companies reporting a working capital deficit to the U.S. Securities and Exchange Commission. Companies with minimum total assets of USD $5 million are covered. Liquidity Alert highlights significant events affecting liquidity, cash flows, estimated capital expenditures, and capital raising efforts.